Patient Worthy is Excited to Announce a New Partnership with The B.L.A.I.R. Connection!

A New Partnership Patient Worthy is honored and excited to announce our new partnership with The B.L.A.I.R. Connection. The B.L.A.I.R. Connection was founded by Grey Chapin who knows firsthand what…

Continue Reading Patient Worthy is Excited to Announce a New Partnership with The B.L.A.I.R. Connection!
Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma
HeungSoon / Pixabay

Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma

According to a story from Korean Biomedical Review, a team of researchers from Seoul National University, headed by professor Paek Sun-ha, have developed an approach utilizing 3D cell printing technology…

Continue Reading Korean Research Team Pioneers Method That Could Personalize Treatment for Glioblastoma
The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?
Pexels / Pixabay

The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?

If you are an avid follower of the latest news, then you have probably heard about one the latest sensational headlines to come out of DC lately: the US Department…

Continue Reading The Department of Education’s 2020 Budget is Requesting Cuts to the Special Olympics and Special Education. What Does This Mean for Rare Patients?

Birth of Healthy Baby Monkey Indicates Promise of New Technique To Preserve Fertility of Childhood Cancer Patients

As the field of medicine has continually advanced, more and more children (now approximately 80%) are surviving cancer diagnoses. It's amazing. It also means that researchers are able to focus…

Continue Reading Birth of Healthy Baby Monkey Indicates Promise of New Technique To Preserve Fertility of Childhood Cancer Patients

New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Acute Myelogenous Leukemia Acute myelogenous leukemia (AML) is a rare blood cancer whose prevalence increases with age. There are still extremely limited treatment options for AML and the five-year survival…

Continue Reading New Potential Combination Therapy for Acute Myelogenous Leukemia has Received Breakthrough Therapy Designation

Yet Another Study Shows the Dire Need for More Diversity in Medical Research

A recent study published in Cell has exhibited the scientific community's negligence for conducting research that includes an adequate representation of non-Europeans. Specifically, it showed that 78% of patients in genomic…

Continue Reading Yet Another Study Shows the Dire Need for More Diversity in Medical Research
Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial
DarkoStojanovic / Pixabay

Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial

According to a story from BioSpace, the biotechnology company Spruce Biosciences recently announced that they have achieved positive proof of concept data in the company's clinical trial. This is a…

Continue Reading Proof of Concept Results Achieved in Congenital Adrenal Hyperplasia Trial

GAPVAC Project Tests An Individualized Form of  Immunotherapy to Treat Aggressive Brain Cancer

A recent article in the journal Nature reports that Phase 1 GAPVAC-101 First-In-Human trial is one of the first clinical trials with a goal of designing and manufacturing actively personalized vaccines…

Continue Reading GAPVAC Project Tests An Individualized Form of  Immunotherapy to Treat Aggressive Brain Cancer
Preventive Use of Extended Half-Life Therapies Provides Enhanced Benefit for Hemophilia A Patients
source: pixabay.com

Preventive Use of Extended Half-Life Therapies Provides Enhanced Benefit for Hemophilia A Patients

According to a story from BioSpace, a recent study revealed that hemophilia A patients were less likely to experience bleeds when they used new, extended half-life therapies on a preventive…

Continue Reading Preventive Use of Extended Half-Life Therapies Provides Enhanced Benefit for Hemophilia A Patients

Recent Discovery Finds a New Genetic Basis for Leukoencephalopathy

According to a story from The McGill Tribune, a little girl named Mathilde Poliquin recently died at the Montreal Children's Hospital. She was only two and half months old and…

Continue Reading Recent Discovery Finds a New Genetic Basis for Leukoencephalopathy